Pathophysiology and Management of Hypotension in Cirrhosis

Pathophysiological Mechanisms

Portal hypertension triggers arterial vasodilation in the splanchnic circulation, causing a decrease in systemic vascular resistance and mean arterial blood pressure 1, 2
The splanchnic vasodilation is a key component of the hyperdynamic circulatory syndrome characteristic of advanced cirrhosis 3
The body attempts to maintain effective plasma volume through activation of the renin-angiotensin-aldosterone system, sympathetic nervous system, and arginine vasopressin secretion 3, 4

Hypotension complicates the management of patients with refractory ascites, as beta-blockers must be used with extreme caution 1, 2
The hyperdynamic circulation and reduced blood pressure contribute to the development of hepatorenal syndrome, particularly in patients with refractory ascites 1, 4
Careful monitoring of blood pressure and renal function is required when using beta-blockers in patients with refractory ascites 1
Volume status assessment is essential in all critically ill cirrhotic patients, as they demonstrate decreased systemic vascular resistance with low arterial blood pressure 5
Balanced crystalloids or albumin are preferred over saline for fluid resuscitation in hypotensive cirrhotic patients 5
Liver transplantation is the definitive treatment for patients with refractory complications of cirrhosis, including persistent hypotension 1

Excessive fluid administration attempting to correct hypotension can worsen ascites and lead to pulmonary edema 4
Vasoconstrictors used to treat hypotension must be carefully selected, as they may further compromise renal perfusion in the setting of hepatorenal syndrome 4